Rafiquendocrine, LLC

Endocrinology in Newark, Delaware

Practice Details

Address
700 Prides Xing Ste 306
Newark, DE 19713
Geocoded location: 39.6805, -75.6963
Taxonomy
Endocrinology, Diabetes & Metabolism
NPPES Enumeration
Recently enumerated with NPPES
Registered Contact
RAAFIA MEMON, OWNER
NPPES Record Updated
June 2025

About This Practice

This practice is enumerated under Endocrinology, Diabetes & Metabolism. Endocrinologists treat hormonal and metabolic conditions including type 2 diabetes, and frequently prescribe GLP-1 medications such as semaglutide or tirzepatide as part of diabetes or metabolic-syndrome management — though not every endocrinology practice treats obesity as a primary focus, and some see only referred, complex cases.

Locally, this is 1 of 10 Endocrinology, Diabetes & Metabolism practices in Newark carrying this exact taxonomy in our directory.

What to expect at an Endocrinology visit

Endocrinology visits focus on hormonal and metabolic conditions. For a GLP-1-related consult, patients commonly encounter:

  • A review of diabetes, thyroid, or metabolic history and current medications.
  • Lab work such as A1c and a metabolic panel to guide diagnosis and dosing.
  • A discussion of whether a GLP-1 medication fits the treatment goal (diabetes control, weight, or both).
  • Follow-up scheduling to titrate dose and monitor response over time.

This is general guidance for endocrinology practices, not a description of Rafiquendocrine, LLC's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 302-240-6886.

GLP-1 access in Newark, Delaware

Adult obesity rate
33.9%
#17 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$215/mo
Typical Delaware telehealth cash price
Medicaid GLP-1 coverage
Diabetes only
Delaware Medicaid, obesity indication

About 33.9% of Delaware adults have obesity (BMI 30+), ranking the state #17 of 50 (CDC BRFSS). Our directory currently lists 29 GLP-1-relevant clinics in Newark. If a cash-pay route makes more sense, compounded semaglutide through Delaware telehealth averages about $215/mo — well below brand-name Wegovy or Zepbound.

Explore more Delaware options on the best Delaware GLP-1 providers page, browse every Newark listing in the Newark clinic directory, or read the Delaware Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Newark

Other Newark listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Delaware addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Delaware telehealth partners:

Featured Partners · Newark

Featured GLP-1 providers serving Newark

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Newark options on the Newark clinic directory, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Newark obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Rafiquendocrine, LLC's specialty taxonomy but not the specific medications it prescribes or its current service menu. Rafiquendocrine, LLC is listed under Endocrinology, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 302-240-6886 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Rafiquendocrine, LLC's primary specialty on file is Endocrinology.
Rafiquendocrine, LLC is located at 700 Prides Xing Ste 306, Newark, DE 19713. The phone number listed in the registry is 302-240-6886. Its full record is public in the CMS National Provider registry under NPI 1972332799.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Rafiquendocrine, LLC is currently accepting new patients. Call the practice at 302-240-6886 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.